Pharmaceuticals & Biotechnology Editor | 03/20/2013
Robert Bronstein, Director Supply Operations at Macrogenics, speaks to Pharma IQ about the lack of visibility in the last mile of the supply chain and suggests ways the industry can overcome this. He also looks ahead to changes in regulations and how that will affect the Clinical Supply Chain.
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma 2026 | AI Commercial, Medical & Patient Care
September 9 - 10, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More
Pharmaceutical Launch Excellence Summit US
September 30 - October 1 2026
Hyatt Regency Boston Harbor, Boston, US
Register Now |
View Agenda |
Learn More